Analyst Profile

Followed by 67 followers
.
Esther Hong

Esther Hong

Loop Capital Markets
Wall Street Analyst
#7,810 out of 8,160 Wall Street Analysts
#23,403 out of 24,427 experts

Success Rate

32%
30 out of 95 transactions made a profit

Average Return

-12.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Esther Hong's trades since 2018 and holding each position for 1 Year would result in 31.58% of your transactions generating a profit, with an average return of -12.8% per rating.

Stock Rating Distribution

142Ratings
82.39% Buy
17.61% Hold
0.00% Sell
Distribution of Esther Hong's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Aldeyra Therapeutics
(ALDX)
Rating:Buy
Date:May 08, 2020 - May 08, 2021
Return:+337.80%
The most profitable rating made by Esther Hong

Esther Hong's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
ContraFect
Jun 28, 2018
Buy
Initiated
$4.00
(2586.37% Upside)
1Ratings
0%
-77.20%
TLC
Taiwan Liposome Company
Dec 17, 2018
Buy
Initiated
2Ratings
0%
-6.20%
Supernus Pharmaceuticals
Jan 31, 2019
Buy
Initiated
$55.00
(54.54% Upside)
1Ratings
0%
-40.00%
Societal CDMO
Jan 31, 2019
Buy
Initiated
$13.00
(715.05% Upside)
1Ratings
100%
+121.90%
BDSI
BioDelivery
Mar 15, 2019
Buy
Reiterated
2Ratings
50%
-1.70%
PLx Pharma
Apr 12, 2019
Buy
Initiated
1Ratings
0%
-52.50%
Collegium Pharmaceutical
Apr 12, 2019
Buy
Initiated
$29.00
(28.32% Upside)
1Ratings
100%
+16.30%
Cara Therapeutics
May 29, 2019
Buy
Reiterated
$33.00
(165.59% Upside)
2Ratings
50%
+1.25%
Agile Therapeutics
Feb 18, 2020
Buy
Reiterated
$9.00
(4311.76% Upside)
3Ratings
67%
+53.07%
Baudax Bio
Apr 08, 2020
Buy
Reiterated
$10.00
(159.74% Upside)
2Ratings
0%
-62.10%
List of latest recommendations made by Esther Hong. Click to expand and see Esther Hong's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >